DNA:NYSE
Ginkgo Bioworks Holdings Inc
10,00 US$
arrow_downward
-0,70%(-0,070) 1 d
20 oct, 9:49:05 GMT-4 · USD
search
Todos los símbolos
| Símbolo | Precio | Cambio | % de cambio |
|---|
insights_autoGenerando estadísticas principales de DNA...
Abrir
10,12 US$
Alto
10,25 US$
Bajo
9,85 US$
Cap. burs.
643,40 M
Vol. medio
3,00 M
Volumen
77,93 mil
Máximo en 52 sem.
18,22 US$
Mínimo en 52 sem.
5,37 US$
BPA
-5,00 US$
Beta
1,79
Acciones en circulación
55,38 M
N.º de empleados
485
Abrir
10,12 US$
Alto
10,25 US$
Bajo
9,85 US$
Cap. burs.
643,40 M
Vol. medio
3,00 M
Volumen
77,93 mil
Máximo en 52 sem.
18,22 US$
Mínimo en 52 sem.
5,37 US$
BPA
-5,00 US$
Beta
1,79
Acciones en circulación
55,38 M
N.º de empleados
485
Noticias
De fuentes web y partners de noticias
Investing.com UK
·
hace 4 horas
Form 144 Ginkgo Bioworks Holdings For: 20 October By Investing.com
Perfil
Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021. Wikipedia
Acerca de Ginkgo Bioworks Holdings Inc
CEOJason Kelly
Empleados485
Fundación2008
SedeBoston, Massachusetts, Estados Unidos
Sector-
Sitio webginkgo.bio